BB&T Investment Services’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$421K Buy
3,913
+3,088
+374% +$330K 0.07% 220
2017
Q3
$93K Buy
825
+105
+15% +$11.2K 0.02% 386
2017
Q2
$77K Buy
720
+219
+44% +$21.6K 0.02% 377
2017
Q1
$48K Buy
501
+12
+2% +$1.15K 0.02% 379
2016
Q4
$44K Buy
+489
New +$44.5K 0.03% 317

Other funds holding IBB

BB&T Investment Services's IBB Position: Q4 2017 in Review

BB&T Investment Services increased its iShares Biotechnology ETF (IBB) stake by 374% in Q4 2017, buying an estimated $330K and bringing the position to 3,913 shares worth $421K. The position accounts for 0.07% of the portfolio, ranked #220.

BB&T Investment Services first reported a position in IBB in Q4 2016 and has held it in 5 quarters since. 624 funds tracked by Wall St. Rank hold IBB as of Q4 2017.

  • BB&T Investment Services held 3,913 shares of iShares Biotechnology ETF worth $421K as of Q4 2017.
  • BB&T Investment Services bought 3,088 iShares Biotechnology ETF shares in Q4 2017, an estimated $330K.
  • iShares Biotechnology ETF made up 0.07% of BB&T Investment Services's portfolio in Q4 2017, its #220 holding.
  • BB&T Investment Services first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 5 quarters since.
  • 624 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2017.

Based on BB&T Investment Services's 13F filing for Q4 2017, filed 15 Feb 2018.